| 614 |
iguratimod
|
-
Iguratimod, CAS-RN: 123663-49-0, DTXSID0048971
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 612 |
curcumin
|
-
Curcumin, CAS-RN: 458-37-7, DTXSID8031077
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 611 |
Pralnacasan (VX-740, HMR3480)
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 609 |
Belnacasan (VX-765)
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 605 |
Emodin
|
-
Emodin, CAS-RN: 518-82-1, DTXSID5025231
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 604 |
Dinoseb
|
-
Dinoseb, CAS-RN: 88-85-7, DTXSID3020207
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 810 |
Forskolin
|
|
558: Phosphodiesterase inhibition leading to heart failure
|
| 813 |
Donepezil
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 814 |
Neostigmine
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 815 |
Pyridostigmine
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 602 |
Carbonyl cyanide m-chlorophenyl hydrazone
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 601 |
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 819 |
Carbaryl
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 822 |
Carbofuran
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 586 |
RB1
|
|
315: Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response
|
| 593 |
Polyoxin D
|
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 770 |
Polyvinyl chloride
|
-
Polyvinyl chloride, CAS-RN: 9002-86-2, DTXSID5025940
|
505: Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway
|
| 595 |
Captan
|
-
Captan, CAS-RN: 133-06-2, DTXSID9020243
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 821 |
Physostigmine
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 820 |
Aldicarb
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 598 |
Exemestane
|
-
Exemestane, CAS-RN: 107868-30-4, DTXSID5023037
|
346: Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation
|
| 599 |
Stressor:292 Clotrimazole
|
|
346: Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation
|
| 816 |
Diazinon
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 817 |
Sarin
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 809 |
Catecholamines
|
|
558: Phosphodiesterase inhibition leading to heart failure
|